In the UK, several GLP-1 receptor agonists are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), each with specific indications: semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management), dulaglutide (Trulicity for type 2 diabetes), and liraglutide (Victoza for type 2 diabetes, Saxenda for weight management)
As a physician, Narang is concerned that the buzz around GLP-1s is shifting attention to medication rather than treating diabetes and obesity as chronic conditions that require long-term, holistic care and medical follow-up
Fukunaka A, Fukada T, Bhin J, Suzuki L, Tsuzuki T, Takamine Y, et al
These agents increase insulin sensitivity in the liver, fat, and muscle, which can help reverse metabolic strain
How PlexusDx Supports a More Personalized Approach PlexusDx Precision Peptide Genetic Test analyzes your predispositions in peptide pathways including GLP-1 receptor sensitivity, appetite regulation (FTO, MC4R), and metabolic adaptation genes
Bethesda: National Center for Biotechnology Information (US)
